MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock and...
$18,699K
Proceeds from the
exercise of stock options
$62K
Issuance of common stock
under employee stock...
$54K
(17.39%↑ Y/Y)
Exercise of pre-funded
warrants in connection...
$5K
Net cash provided
by/(used in) financing...
$18,806K
(630.79%↑ Y/Y)
Canceled cashflow
$14K
Net
(decrease)/increase in cash, cash...
-$4,776K
(-174.00%↓ Y/Y)
Canceled cashflow
$18,806K
Proceeds from maturities
of marketable...
$19,951K
(-25.42%↓ Y/Y)
Stock-based compensation
expense
$2,424K
(-66.41%↓ Y/Y)
Prepaid expenses and
other current assets
-$567K
(30.85%↑ Y/Y)
Non-cash operating lease
expense
$477K
(-50.05%↓ Y/Y)
Depreciation and
amortization
$152K
(-69.04%↓ Y/Y)
Tax withholdings
paid on behalf of...
$9K
(-70.97%↓ Y/Y)
Proceeds from exercise of
warrants for common...
-$5K
(-100.13%↓ Y/Y)
Net cash (used
in)/provided by investing...
-$14,556K
(-160.80%↓ Y/Y)
Canceled cashflow
$19,951K
Net cash used in
operating activities
-$9,026K
(35.27%↑ Y/Y)
Canceled cashflow
$3,620K
Purchases of marketable
securities
$34,475K
(1167.46%↑ Y/Y)
Purchases of property and
equipment
$32K
(-63.64%↓ Y/Y)
Net loss
-$8,421K
(64.86%↑ Y/Y)
Deferred revenue
-$1,708K
Accrued expenses and
other current...
-$1,569K
(-381.18%↓ Y/Y)
Operating lease
liabilities
-$477K
(50.00%↑ Y/Y)
Net accretion and
amortization of investments...
$267K
(68.99%↑ Y/Y)
Accounts payable
-$204K
(-146.47%↓ Y/Y)
Back
Back
Cash Flow
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)
source: myfinsight.com